Silence Therapeutics SLN
NASDAQ SLN
$14.59 -0.20 (-1.35%)
As of: Sep 4, 2026 · 3:59 PM EDT

Silence Therapeutics (SLN) Prepaid Assets (2023 - 2026)

Silence Therapeutics (SLN) posted Prepaid Assets of $10.6 million for Q1 2026, down 8.49% sequentially from $11.5 million in Q4 2025, and down 35.7% YoY from $16.4 million in Q1 2025.

Analysis

Silence Therapeutics (SLN) Prepaid Assets (2023 - 2026) Analysis & Trends

Silence Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $10.6 million in Q1 2026.

  • Quarterly Prepaid Assets fell 35.7% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 35.7% YoY) and the FY2025 annual result came in at $11.5 million, down 21.32% from the prior year.
  • Prepaid Assets slipped to $10.6 million in Q1 2026 per SLN's latest filing, from $11.5 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $16.4 million in Q1 2025 and troughed at $9.3 million in Q3 2025.
  • A 5-year average of $12.2 million and a median of $11.4 million in 2025 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2022 and 2026: Prepaid Assets surged 65.58% in 2022, then tumbled 35.7% in 2026.
  • Over 5 years, Prepaid Assets stood at $9.6 million in 2022, then grew by 17.88% to $11.3 million in 2023, then gained by 29.34% to $14.7 million in 2024, then retreated by 21.32% to $11.5 million in 2025, then slipped by 8.49% to $10.6 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $10.6 million, $11.5 million, and $9.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Silence Therapeutics 690.60 Mn 618.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.94 Mn
Mar 31, 2026 10.56 Mn
Dec 31, 2025 11.54 Mn
Sep 30, 2025 9.26 Mn
Jun 30, 2025 14.36 Mn
Mar 31, 2025 16.42 Mn
Dec 31, 2024 14.66 Mn
Dec 31, 2023 11.63 Mn